These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 8676919)

  • 1. Spontaneous mutants recovered from liver and germ cell tissue of low copy number lacI transgenic rats.
    de Boer JG; Erfle H; Holcroft J; Walsh D; Dycaico M; Provost S; Short J; Glickman BW
    Mutat Res; 1996 Jun; 352(1-2):73-8. PubMed ID: 8676919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The genetic analysis of lacI mutations in sectored plaques from Big Blue transgenic mice.
    Stuart GR; Gorelick NJ; Andrews JL; de Boer JG; Glickman BW
    Environ Mol Mutagen; 1996; 28(4):385-92. PubMed ID: 8991067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 1,3-butadiene: cancer, mutations, and adducts. Part II: Roles of two metabolites of 1,3-butadiene in mediating its in vivo genotoxicity.
    Recio L; Saranko CJ; Steen AM
    Res Rep Health Eff Inst; 2000 Mar; (92):49-87; discussion 141-9. PubMed ID: 10925839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transmission of mutations in the lacI transgene to the offspring of ENU-treated Big Blue male mice.
    Barnett LB; Tyl RW; Shane BS; Shelby MD; Lewis SE
    Environ Mol Mutagen; 2002; 40(4):251-7. PubMed ID: 12489115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An efficient laboratory protocol for the sequencing of large numbers of lacI mutants recovered from Big Blue transgenic animals.
    Erfle HL; Walsh DF; Holcroft J; Hague N; de Boer JG; Glickman BW
    Environ Mol Mutagen; 1996; 28(4):393-6. PubMed ID: 8991068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Database and software for the analysis of mutations at the lacI gene in both transgenic rodents and bacteria.
    Cariello NF; Gorelick NJ
    Environ Mol Mutagen; 1996; 28(4):397-404. PubMed ID: 8991069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutational spectra of tamoxifen-induced mutations in the livers of lacI transgenic rats.
    Davies R; Oreffo VI; Bayliss S; Dinh PA; Lilley KS; White IN; Smith LL; Styles JA
    Environ Mol Mutagen; 1996; 28(4):430-3. PubMed ID: 8991074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased mutant frequency and altered mutation spectrum of the lacI transgene in Wilson disease rats with hepatitis.
    Sone H; Li YJ; Ishizuka M; Aoki Y; Nagao M
    Cancer Res; 2000 Sep; 60(18):5080-6. PubMed ID: 11016632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of mutant frequencies at the transgenic lambda LacI and cII/cI loci in control and ENU-treated Big Blue mice.
    Zimmer DM; Harbach PR; Mattes WB; Aaron CS
    Environ Mol Mutagen; 1999; 33(3):249-56. PubMed ID: 10334627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spectrum of mutations in kidney, stomach, and liver from lacI transgenic mice recovered after treatment with tris(2,3-dibromopropyl)phosphate.
    de Boer JG; Mirsalis JC; Provost GS; Tindall KR; Glickman BW
    Environ Mol Mutagen; 1996; 28(4):418-23. PubMed ID: 8991072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parameters affecting the use of the lac repressor system in eukaryotic cells and transgenic animals.
    Wyborski DL; DuCoeur LC; Short JM
    Environ Mol Mutagen; 1996; 28(4):447-58. PubMed ID: 8991077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel germline mutation in Big Blue mice.
    Crabbe RA; Prtenjaca A; Tarnowski HE; Hill KA
    Environ Mol Mutagen; 2009 Mar; 50(2):114-20. PubMed ID: 19107908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tissue-specific mutant frequencies and mutational spectra in cyclophosphamide-treated lacI transgenic mice.
    Gorelick NJ; Andrews JL; deBoer JG; Young R; Gibson DP; Walker VE
    Environ Mol Mutagen; 1999; 34(2-3):154-66. PubMed ID: 10529740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutagenic response of the endogenous hprt gene and lacI transgene in benzo[a]pyrene-treated Big Blue B6C3F1 mice.
    Skopek TR; Kort KL; Marino DR; Mittal LV; Umbenhauer DR; Laws GM; Adams SP
    Environ Mol Mutagen; 1996; 28(4):376-84. PubMed ID: 8991066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A strategy for the application of transgenic rodent mutagenesis assays.
    Gorelick NJ; Mirsalis JC
    Environ Mol Mutagen; 1996; 28(4):434-42. PubMed ID: 8991075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutational spectrum of dimethylnitrosamine in the liver of 3- and 6-week-old lacI transgenic mice.
    de Boer JG; Mirsalis JC; Glickman BW
    Environ Mol Mutagen; 1999; 34(2-3):80-3. PubMed ID: 10529729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spectrum of spontaneous mutations in liver tissue of lacI transgenic mice.
    de Boer JG; Erfle H; Walsh D; Holcroft J; Provost JS; Rogers B; Tindall KR; Glickman BW
    Environ Mol Mutagen; 1997; 30(3):273-86. PubMed ID: 9366905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A selectable system for mutation detection in the Big Blue lacI transgenic mouse system: what happens to the mutational spectra over time.
    Knöll A; Jacobson DP; Nishino H; Kretz PL; Short JM; Sommer SS
    Mutat Res; 1996 Jun; 352(1-2):9-22. PubMed ID: 8676922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutagenic response to benzene and tris(2,3-dibromopropyl)-phosphate in the lambda lacI transgenic mouse mutation assay: a standardized approach to in vivo mutation analysis.
    Provost GS; Mirsalis JC; Rogers BJ; Short JM
    Environ Mol Mutagen; 1996; 28(4):342-7. PubMed ID: 8991062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Species-specific differences in hepatic mutant frequency and mutational spectrum among lambda/lacI transgenic rats and mice following exposure to aflatoxin B1.
    Dycaico MJ; Stuart GR; Tobal GM; de Boer JG; Glickman BW; Provost GS
    Carcinogenesis; 1996 Nov; 17(11):2347-56. PubMed ID: 8968048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.